Thematic review series: The immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease.
about
Emerging role of mast cells and macrophages in cardiovascular and metabolic diseasesInflammatory mechanisms linking periodontal diseases to cardiovascular diseasesRegulation of atherogenesis by chemokine receptor CCR6Genetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred StrainsTxnip ablation reduces vascular smooth muscle cell inflammation and ameliorates atherosclerosis in apolipoprotein E knockout miceIGF-1, oxidative stress and atheroprotectionSrc-dependent STAT-3-mediated expression of monocyte chemoattractant protein-1 is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migrationVascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosisRole of smooth muscle cells in the initiation and early progression of atherosclerosis.Increased percentages of T cells producing interleukin-21 in patients with immune thrombocytopenic purpura.Development of a Glycosaminoglycan Derived, Selectin Targeting Anti-Adhesive Coating to Treat Endothelial Cell Dysfunction.Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor NF-kappaB signaling.Genetic network identifies novel pathways contributing to atherosclerosis susceptibility in the innominate arteryIl-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability.Regulation of CCL5 expression in smooth muscle cells following arterial injuryDiabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature.A systems biology approach to understanding atherosclerosis.Integrative pathway dissection of molecular mechanisms of moxLDL-induced vascular smooth muscle phenotype transformationThe interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats.Anti-inflammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility.Stimulatory interactions between human coronary smooth muscle cells and dendritic cells.Progenitor cells in pulmonary vascular remodeling.FoxO4 inhibits atherosclerosis through its function in bone marrow derived cells.Interleukin-19 (IL-19) induces heme oxygenase-1 (HO-1) expression and decreases reactive oxygen species in human vascular smooth muscle cells.Aging, atherosclerosis, and IGF-1Smooth muscle-specific expression of calcium-independent phospholipase A2β (iPLA2β) participates in the initiation and early progression of vascular inflammation and neointima formationCXCL5 signaling is a shared pathway of neuroinflammation and blood-brain barrier injury contributing to white matter injury in the immature brain.Role of Renin-Angiotensin system and oxidative stress on vascular inflammation in insulin resistence model.Expression and suppressive effects of interleukin-19 on vascular smooth muscle cell pathophysiology and development of intimal hyperplasia.Cardiovascular actions of the peroxisome proliferator-activated receptor-alpha (PPARalpha) agonist Wy14,643.The Effect of Sodium Tanshinone IIA Sulfate and Simvastatin on Elevated Serum Levels of Inflammatory Markers in Patients with Coronary Heart Disease: A Study Protocol for a Randomized Controlled Trial.Atherosclerosis as a disease of failed endogenous repairTLR3 deficiency protects against collagen degradation and medial destruction in murine atherosclerotic plaques.Role of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cellsRole of the lysine-specific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice.Ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) and nuclear factor-κB (NF-κB): a feed-forward loop for systemic and vascular inflammation.Cholesterol, cytokines and diseases.Inflammation in atherosclerosis: a cause or a result of vascular disorders?Anti-inflammatory effects of interleukin-19 in vascular disease.
P2860
Q26825467-4DBF58DB-2FF8-41BB-BFD0-B46465B8F884Q26997381-B25ACBF8-57ED-4CB7-BE58-C089A9C69A8FQ27023950-3725E7E9-19FB-4FA0-9E0B-80FB4AD352D9Q27309881-0FE8F507-580F-473B-B4E2-DA617E148FAAQ27332439-31A79E49-C4C2-4245-9429-98B92AF9C264Q27694593-25D042FA-5209-4F81-8572-1464995A0BACQ28565946-17660710-ECE6-4A68-81FD-49F4FBD3B606Q30319434-64B26632-4579-431A-8243-56AB85CD6F26Q30433361-C0C2BE6A-4AC8-4E7C-BBB5-87CDF05189EAQ30438867-EC14FCEC-D842-460F-A4BF-F5D79325AF78Q33412014-74DC3566-4737-4827-B98C-8B118B68B3B2Q33851498-704EBE64-6BE3-4509-A8CA-BBD648061478Q33869955-8EC25586-CB09-453B-8A10-FAA3B3FB5078Q34079474-0A9853B3-53EC-4A12-ACCE-3A8B2B01DBF0Q34101299-27D4C6C2-E5F7-4844-81F2-5F0BC6908853Q34146505-A49832A1-DCA7-4069-A128-8FB7A21B2533Q34350546-D30B8E22-4108-47D5-9796-20455BA7C8A7Q34355117-3788D29C-CA9E-4838-9B21-AF9F46A61159Q34549788-00A6C9E0-C866-4A0D-BB18-2A17380C77A9Q34769627-8A79F081-2368-4A15-97A2-7D64EEF84C2CQ34782136-9FB22AC9-FE09-4913-A776-C5FA2465FA13Q35188689-DE05DA6B-CB65-469B-848C-08FA711F6FA3Q35412268-0430597C-E7FB-4C48-B42C-E1C47A3BB503Q35581071-4387F36C-7D75-40AF-AE5A-F06C7917B5F5Q35709881-84FF4EB9-0B96-48C2-BDED-D6782A365AC3Q35947440-B8D86589-72D7-45FA-9443-0D25258957BFQ36098088-02FD50D4-D494-4A2F-AFB1-2F1E38CDA101Q36439707-F24E21A4-8FBE-4417-BFA3-AEEB5F470926Q36566170-E1F2EFD9-BEDF-4884-A80F-38D6BB6761C1Q36855687-6E0856FA-3FE5-4358-9220-D1FDBEAB5373Q36872068-966ECBCA-E089-4822-84EE-DB63BCD1FB40Q37105698-DAD2E098-50D7-4E50-84F5-A7B07D60A5A2Q37152177-9897C97A-35F8-4B75-BAA6-77C28B32CD9BQ37166308-E9802A9D-8B90-428F-B3FB-3EC70505FA02Q37168707-8ADDC64C-873C-4EC1-B788-923ADB068F47Q37219745-BBC76111-9D83-4B5B-B8E9-58F52E9B2B04Q37405006-D3244890-F662-4244-B650-099A94D138F5Q37943057-0949159E-292A-4EC5-B54C-7BBAA22899EDQ37986175-821D30D3-4654-4327-85A7-CB7463C42015Q38030546-C47ECA32-7AE7-4847-9E93-A9AF5B3D078F
P2860
Thematic review series: The immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Thematic review series: The im ...... cle cells in vascular disease.
@ast
Thematic review series: The im ...... cle cells in vascular disease.
@en
type
label
Thematic review series: The im ...... cle cells in vascular disease.
@ast
Thematic review series: The im ...... cle cells in vascular disease.
@en
prefLabel
Thematic review series: The im ...... cle cells in vascular disease.
@ast
Thematic review series: The im ...... cle cells in vascular disease.
@en
P2860
P1476
Thematic review series: The im ...... scle cells in vascular disease
@en
P2093
Elaine W Raines
P2860
P304
P356
10.1194/JLR.R500004-JLR200
P50
P577
2005-04-16T00:00:00Z